Predicting Chemosensitivity to Gemcitabine and Cisplatin Based on Gene Polymorphisms and mRNA Expression in Non-Small-Cell Lung Cancer Cells
- 6 January 2015
- journal article
- Published by Taylor & Francis in Pharmacogenomics
- Vol. 16 (1) , 23-34
Abstract
Aim: We used a panel of 17 non-small-cell lung cancer cell lines to investigate whether the presence of polymorphisms in the RRM1, ERCC1, ABCB1 and MTHFR genes and alterations in their mRNA expression can affect the in vitro chemosensitivity to cisplatin and gemcitabine. Materials & methods: Polymorphisms in these genes were evaluated by direct sequencing. mRNA expression levels were assessed by realtime PCR. In vitro chemosensitivity to cisplatin and gemcitabine was expressed as IC50 values, using the MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) assay. Results: There was a significant, positive correlation between RRM1 mRNA expression and IC50 values for gemcitabine (r = 0.6533, p = 0.0045), and there was a significant, negative correlation between ABCB1 mRNA expression and IC50 values for cisplatin (r = -0.5459, p = 0.0287). When examining the association between the polymorphisms and IC50, we found that only the MTHFR 1298A>C polymorphism showed a tendency to be more chemosensitiv...Keywords
Funding Information
- International Science & Technology Cooperation Program (2013DFA31610)
- the Program for Changjiang Scholars and Innovative Research Team (IRT1230)
- the National Natural Science Foundation (NO.81372784, NO.81101646)
- The Natural Science Foundation in Heilongjiang Province (QC08C90)
- The New Century Support Program
- Ministry of Education (NCET-10-0149, NCET-11-0954)
This publication has 58 references indexed in Scilit:
- Resistance to Paclitaxel in a Cisplatin-Resistant Ovarian Cancer Cell Line Is Mediated by P-GlycoproteinPLOS ONE, 2012
- Meta-Analysis on Pharmacogenetics of Platinum-Based Chemotherapy in Non Small Cell Lung Cancer (NSCLC) PatientsPLOS ONE, 2012
- Gemcitabine metabolic pathway genetic polymorphisms and response in patients with non-small cell lung cancerPharmacogenetics and Genomics, 2012
- ATP‐binding cassette B1 gene polymorphisms, mRNA expression and chemosensitivity to paclitaxel in non‐small cell lung cancer cellsRespirology, 2011
- Lung Cancer Cell Lines as Tools for Biomedical Discovery and ResearchJNCI: Journal of the National Cancer Institute, 2010
- Pharmacogenomic Discovery Using Cell-Based ModelsPharmacological Reviews, 2009
- Tumor BRCA1, RRM1 and RRM2 mRNA Expression Levels and Clinical Response to First-Line Gemcitabine plus Docetaxel in Non-Small-Cell Lung Cancer PatientsPLOS ONE, 2008
- Nuclear excision repair-based personalized therapy for non-small cell lung cancer: From hypothesis to realityThe International Journal of Biochemistry & Cell Biology, 2007
- The NCI60 human tumour cell line anticancer drug screenNature Reviews Cancer, 2006
- Cellular processing of platinum anticancer drugsNature Reviews Drug Discovery, 2005